Oral premalignant lesions: is a biopsy reliable?
- PMID: 17448135
- DOI: 10.1111/j.1600-0714.2007.00513.x
Oral premalignant lesions: is a biopsy reliable?
Abstract
Purpose: The purpose of the present retrospective study was to learn whether a biopsy of oral premalignant lesions, leukoplakia and erythroplakia, shows histopathological findings representative of the whole surgically removed lesion. Moreover, to see whether histopathological characteristics of the whole lesion are significant for future malignant development after surgery.
Materials and methods: A total of 101 lesions in 96 patients were included, 42 lesions (41%) being homogenous and 50 (50%) non-homogenous leukoplakias, whereas nine (9%) were erythroplakias. The lesions were biopsied and subsequently surgically removed on the average of 10.4 months after biopsy. Surgical specimens were examined in two or more step sections distributed throughout the specimen. The histological findings of the biopsies were compared with those of the whole lesions. After surgical intervention the patients were followed (mean 6.8 years, range: 1.5-18.6), and new biopsies taken in case of recurrences. Smokers (73%) were encouraged to quit smoking and candidal infections were treated. The possible influence of different variables on the risk of malignant development was estimated by means of logistic regression analysis.
Results: Histological examination of the whole lesions showed that seven lesions (7%) harboured a carcinoma and 70 lesions (69%) showed a degree of epithelial dysplasia or carcinoma in situ. Eleven lesions (12%) developed carcinoma after a mean follow-up period of 7.5 years. A comparison of the degree of dysplasia in the biopsies with that of the whole lesion demonstrated variation with concurrent diagnosis in 49% of the lesions and in 79% after inclusion of lesions with one degree up or down the scale of epithelial dysplasia.
Conclusion: The estimated odds ratio showed that none of the associated variables including presence of any degree of epithelial dysplasia in the whole lesion, site, demarcation and smoking had influence on the risk of malignant development.
Similar articles
-
Long-term treatment outcome of oral premalignant lesions.Oral Oncol. 2006 May;42(5):461-74. doi: 10.1016/j.oraloncology.2005.08.011. Epub 2005 Nov 28. Oral Oncol. 2006. PMID: 16316774
-
The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions.Int J Oral Maxillofac Surg. 2009 Nov;38(11):1188-93. doi: 10.1016/j.ijom.2009.06.026. Epub 2009 Jul 28. Int J Oral Maxillofac Surg. 2009. PMID: 19640683
-
Effective management of smoking in an oral dysplasia clinic in London.Oral Dis. 2006 Jan;12(1):22-6. doi: 10.1111/j.1601-0825.2005.01146.x. Oral Dis. 2006. PMID: 16390464
-
The diagnosis and treatment of precancerous lesions.FDI World. 1995 Mar-Apr;4(2):6-9. FDI World. 1995. PMID: 9552676 Review.
-
The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.Oral Oncol. 2005 Jan;41(1):31-7. doi: 10.1016/j.oraloncology.2004.06.010. Oral Oncol. 2005. PMID: 15598583 Review.
Cited by
-
Improvement in the risk assessment of oral leukoplakia through morphology-related copy number analysis.Sci China Life Sci. 2021 Sep;64(9):1379-1391. doi: 10.1007/s11427-021-1965-x. Epub 2021 Aug 2. Sci China Life Sci. 2021. PMID: 34351567
-
Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis.Lasers Med Sci. 2019 Feb;34(1):209-221. doi: 10.1007/s10103-018-2674-7. Epub 2018 Nov 15. Lasers Med Sci. 2019. PMID: 30443884
-
A brief review of common oral premalignant lesions with emphasis on their management and cancer prevention.Indian J Surg. 2011 Aug;73(4):256-61. doi: 10.1007/s12262-011-0286-6. Epub 2011 Apr 28. Indian J Surg. 2011. PMID: 22851837 Free PMC article.
-
Screening for mouth cancer: the pros and cons of a national programme.Br Dent J. 2018 Nov 9;225(9):815-819. doi: 10.1038/sj.bdj.2018.918. Br Dent J. 2018. PMID: 30412550 Review.
-
Oral pathology in a population observed within an oral cancer screening developed in Portugal.Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e107-e116. doi: 10.4317/medoral.26863. Med Oral Patol Oral Cir Bucal. 2025. PMID: 39582407 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical